The Gates Foundation has announced a $220 million grant to a US-based not-for-profit biotech to develop modern vaccines to combat TB against the backdrop of a significant increase in drug-resistant strains, First Post reported.
The World Health Organisation estimates the global economic burden of TB at nearly $12 billion a year, with India and China together accounting for more than half the global economic toll.e world’s largest not-for-profit biotechs, Aeras announced it is recipient of a grant by he Bill & Melinda Gates Foundation of up to $220 million over five One of the world’s largest not-for-profit biotechs, Aeras announced it is recipient of a grant by the Bill & Melinda Gates Foundation of up to $220 million over five years, placing it at the forefront of a global scientific initiative aimed at developing safe, effective vaccines against tuberculosis, a disease that infects two billion people worldwide.
“This infusion of funding must be seen as a global call to action in response to one of the world’s deadliest diseases,” said Jim Connolly, president and CEO of Aeras.
No comments:
Post a Comment